Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,595 | -20,184 | -68,002 | -139,805 | -8,908 |
| Depreciation Amortization | 4,687 | 8,661 | 12,308 | 16,490 | 12,986 |
| Income taxes - deferred | 65 | -64 | -62 | -5,238 | -20,127 |
| Accounts receivable | 264 | -2,899 | 15,351 | -10,753 | -10,132 |
| Accounts payable and accrued liabilities | -2,086 | 26 | -8,425 | 414 | 2,018 |
| Other Working Capital | -8,909 | 227 | 1,467 | -14,905 | -2,258 |
| Other Operating Activity | 30,689 | 22,664 | 34,865 | 145,309 | 21,828 |
| Operating Cash Flow | $20,115 | $8,431 | $-12,498 | $-8,488 | $-4,593 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,478 | -3,227 | -6,381 | -10,385 | -8,380 |
| Net Acquisitions | 23,516 | 60,392 | N/A | N/A | 1,559 |
| Purchase Of Investment | -114,063 | -18,415 | -27,095 | -53,116 | N/A |
| Sale Of Investment | 41,593 | 21,918 | 56,169 | 8,920 | N/A |
| Purchase Sale Intangibles | N/A | -300 | N/A | N/A | N/A |
| Other Investing Activity | -13,107 | -2,368 | -4,856 | -3,536 | -6,371 |
| Investing Cash Flow | $-71,539 | $58,300 | $17,837 | $-58,117 | $-13,192 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 27,306 |
| Debt Issued | N/A | N/A | N/A | 20,000 | 1,550 |
| Debt Repayment | -10,000 | -6,608 | -498 | -2,164 | -214 |
| Common Stock Issued | 18 | 202 | 10,751 | 323 | 1,418 |
| Other Financing Activity | -942 | -377 | 338 | -1,843 | -32,838 |
| Financing Cash Flow | $-10,924 | $-6,783 | $10,591 | $16,316 | $-2,778 |
| Exchange Rate Effect | N/A | N/A | 35 | -108 | -23 |
| Beginning Cash Position | 95,386 | 35,438 | 19,473 | 69,870 | 90,456 |
| End Cash Position | 33,038 | 95,386 | 35,438 | 19,473 | 69,870 |
| Net Cash Flow | $-62,348 | $59,948 | $15,965 | $-50,397 | $-20,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,115 | 8,431 | -12,498 | -8,488 | -4,593 |
| Capital Expenditure | -9,478 | -3,227 | -6,381 | -10,385 | -8,385 |
| Free Cash Flow | 10,637 | 5,204 | -18,879 | -18,873 | -12,978 |